Animal StudyPubMed ID: 12814794·2003

Epithalon Inhibits Tumor Promotion and Extends Median Lifespan in Carcinogen-Treated Aging Mice

Anisimov VN, Popovich IG, Zabezhinski MA, et al.

Experimental Gerontology, 2003

Key finding

Epithalon reduced overall tumor incidence by 48%, delayed tumor onset by 89 days, and increased lifespan 12%.

Summary

Study of epithalon effects on carcinogen (DMBA)-induced tumorigenesis and lifespan in aging mice with documentation of tumor incidence.

Read the study

The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.

View on PubMed

Related compound

EpithalonL2

A tetrapeptide studied for its potential to activate telomerase and extend cellular lifespan, primarily in Russian research.

More research on Epithalon

Epithalon Improves Cognitive Function and Reverses Age-Related Memory Decline in Mice

Neuroendocrinology Letters · 2009 · Animal Study

Epithalon Promotes Retinal Ganglion Cell Survival and Axonal Regeneration in Optic Nerve Damage Models

Journal of Ocular Pharmacology and Therapeutics · 2008 · Animal Study

Telomerase Reactivation and Telomere Length Restoration by Epithalon in Cultured Human Lymphocytes

Bulletin of Experimental Biology and Medicine · 2008 · In Vitro

Epithalon Effects on Cellular Senescence and p16/INK4a Expression in Aging Fibroblasts

Bulletin of Experimental Biology and Medicine · 2007 · In Vitro

Epithalon Increases BDNF Expression and Promotes Neurogenesis in Aging Hippocampus

Neuroscience · 2007 · Animal Study